|
|
||||||||
1From the Departments of Ophthalmology, 4Physiologic Science, and 5Pathology and Laboratory Medicine, University of California, Los Angeles, California; the 3Department of Oral Molecular Biology, Oregon Health Sciences University, Portland, Oregon; and the 6Department of Surgery, West Los Angeles Veterans Affairs Medical Center, Los Angeles, California.
PURPOSE. Perineuclear anti-neutrophil cytoplasmic antibody (pANCA), a marker antibody present in 12% of patients with anterior uveitis, recognizes cytoplasmic antigens in the nonpigmented ciliary body epithelium, a probable site of immunologic reactivity in this inflammatory disease. In this study, a recombinantly isolated pANCA monoclonal antibody was used to identify the corresponding antigenic target(s) in the ciliary body.
METHODS. Proteins from microdissected eye bank ocular ciliary body tissue were used to identify the corresponding ANCA antigen. Parallel two-dimensional protein gels were used for simultaneous identification of candidate antigenic protein spots by Western blot analysis and as a source of material for proteomic analysis. Multiple independent methods including Western blot analysis, confocal microscopy, and RT-PCR were used to provide additional characterization of the candidate protein.
RESULTS. Proteomic analysis suggested that beta B1 (ßB1)-crystallin is the primary ciliary body antigen. The presence of ßB1-crystallin in the human ciliary body was confirmed by Western blot with a ßB1 specific anti-peptide antibody. Confocal microscopy revealed colocalization of the antigenic reactivity of both anti-ßB1 antibody and monoclonal pANCA. RT-PCR confirmed the presence of ßB1-crystallin RNA in the ciliary body tissues.
CONCLUSIONS. This study identified ßB1-crystallin as a new cytoplasmic ciliary body antigenic target of a marker autoantibody associated with uveitis. This characterization of ßB1-crystallin outside the lens raises questions about its extralenticular expression, intracellular role, and potential target of inflammation in uveitis.
This article has been cited by other articles:
![]() |
L. Chen, G. N. Holland, F. Yu, R. D. Levinson, K. J. Lampi, J. Horwitz, and L. K. Gordon Associations of Seroreactivity against Crystallin Proteins with Disease Activity and Cataract in Patients with Uveitis Invest. Ophthalmol. Vis. Sci., October 1, 2008; 49(10): 4476 - 4481. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Descamps, E. Martens, P. Proost, S. Starckx, P. E. Van den Steen, J. Van Damme, and G. Opdenakker Gelatinase B/matrix metalloproteinase-9 provokes cataract by cleaving lens {beta}B1 crystallin FASEB J, January 1, 2005; 19(1): 29 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, C. M. Garcia, Y.-B. Shui, and D. C. Beebe Expression and Regulation of {alpha}-, {beta}-, and {gamma}-Crystallins in Mammalian Lens Epithelial Cells Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3608 - 3619. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Bora, J.-H. Sohn, S.-G. Kang, J. M. C. Cruz, H. Nishihori, H.-J. Suk, Y. Wang, H. J. Kaplan, and P. S. Bora Type I Collagen Is the Autoantigen in Experimental Autoimmune Anterior Uveitis J. Immunol., June 1, 2004; 172(11): 7086 - 7094. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |